{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T05:21:07Z","timestamp":1791523267407,"version":"4.3.4"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,17]],"date-time":"2024-07-17T00:00:00Z","timestamp":1721174400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007165","name":"University of Missouri","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007165","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nuclear Medicine and Biology"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.nucmedbio.2024.108938","type":"journal-article","created":{"date-parts":[[2024,7,14]],"date-time":"2024-07-14T16:42:39Z","timestamp":1720975359000},"page":"108938","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Evaluation of a bimodal, matched pair theranostic agent targeting prostate-specific membrane antigen"],"prefix":"10.1016","volume":"136-137","author":[{"given":"Michael R.","family":"Lewis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander W.","family":"Schaedler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khanh-Van","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mojgan","family":"Golzy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anupam","family":"Mathur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Pun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Gallazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa D.","family":"Watkinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terry L.","family":"Carmack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanishka","family":"Sikligar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn J.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles J.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nucmedbio.2024.108938_bb0005","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.nucmedbio.2024.108938_bb0010","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1021\/acs.bioconjchem.1c00537","article-title":"Strain-promoted azide\u2013alkyne cycloaddition-based PSMA-targeting ligands for multimodal intraoperative tumor detection of prostate cancer","volume":"33","author":"Derks","year":"2022","journal-title":"Bioconjug Chem"},{"key":"10.1016\/j.nucmedbio.2024.108938_bb0015","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.eururo.2016.08.003","article-title":"EAU-ESTRO-SIOG guidelines on prostate cancer. Part 1: screening, diagnosis, and local treatment with curative intent","volume":"71","author":"Mottet","year":"2017","journal-title":"Eur Urol"},{"key":"10.1016\/j.nucmedbio.2024.108938_bb0020","doi-asserted-by":"crossref","first-page":"6824","DOI":"10.7150\/thno.36739","article-title":"PSMA-targeting agents for radio- and fluorescence-guided prostate cancer surgery","volume":"9","author":"Derks","year":"2019","journal-title":"Theranostics"},{"key":"10.1016\/j.nucmedbio.2024.108938_bb0025","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.eururo.2013.07.039","article-title":"Positive surgical margins after radical prostatectomy: a systematic review and contemporary update","volume":"65","author":"Yossepowitch","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.nucmedbio.2024.108938_bb0030","doi-asserted-by":"crossref","first-page":"995","DOI":"10.2967\/jnumed.114.138180","article-title":"Dual-modality image-guided surgery of prostate cancer with a radiolabeled fluorescent anti-PSMA monoclonal antibody","volume":"55","author":"L\u00fctje","year":"2014","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2024.108938_bb0035","doi-asserted-by":"crossref","first-page":"67s","DOI":"10.2967\/jnumed.116.186767","article-title":"Prostate-specific membrane antigen ligands for imaging and therapy","volume":"58","author":"Eiber","year":"2017","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2024.108938_bb0040","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1021\/jm000406m","article-title":"Design of remarkably simple, yet potent urea-based inhibitors of glutamate carboxypeptidase II (NAALADase)","volume":"44","author":"Kozikowski","year":"2001","journal-title":"J Med Chem"},{"key":"10.1016\/j.nucmedbio.2024.108938_bb0045","doi-asserted-by":"crossref","first-page":"2924","DOI":"10.7150\/thno.35274","article-title":"Development and characterization of a theranostic multimodal anti-PSMA targeting agent for imaging, surgical guidance, and targeted photodynamic therapy of PSMA-expressing tumors","volume":"9","author":"L\u00fctje","year":"2019","journal-title":"Theranostics"},{"key":"10.1016\/j.nucmedbio.2024.108938_bb0050","doi-asserted-by":"crossref","first-page":"314","DOI":"10.3389\/fonc.2017.00314","article-title":"Fluorescence-guided surgery","volume":"7","author":"Nagaya","year":"2017","journal-title":"Front Oncol"},{"key":"10.1016\/j.nucmedbio.2024.108938_bb0055","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1158\/1535-7163.MCT-14-0422","article-title":"Development of targeted near-infrared imaging agents for prostate cancer","volume":"13","author":"Wang","year":"2014","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.nucmedbio.2024.108938_bb0060","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/med.21508","article-title":"Targeting prostate cancer: prostate-specific membrane antigen based diagnosis and therapy","volume":"39","author":"Wustemann","year":"2019","journal-title":"Med Res Rev"},{"key":"10.1016\/j.nucmedbio.2024.108938_bb0065","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.2967\/jnumed.120.259796","article-title":"Optical navigation of the drop-in \u03b3-probe as a means to strengthen the connection between robot-assisted and radioguided surgery","volume":"62","author":"Azargoshasb","year":"2021","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2024.108938_bb0070","doi-asserted-by":"crossref","first-page":"235","DOI":"10.2967\/jnumed.116.178939","article-title":"Preclinical evaluation and first patient application of 99mTc-PSMA-I&S for SPECT imaging and radioguided surgery in prostate cancer","volume":"58","author":"Robu","year":"2017","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2024.108938_bb0075","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s13550-015-0147-6","article-title":"[(111)In]PSMA-I&T: expanding the spectrum of PSMA-I&T applications towards SPECT and radioguided surgery","volume":"5","author":"Schottelius","year":"2015","journal-title":"EJNMMI Res"},{"key":"10.1016\/j.nucmedbio.2024.108938_bb0080","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.eururo.2018.03.013","article-title":"(99m)Technetium-based prostate-specific membrane antigen-radioguided surgery in recurrent prostate cancer","volume":"75","author":"Maurer","year":"2019","journal-title":"Eur Urol"},{"key":"10.1016\/j.nucmedbio.2024.108938_bb0085","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1007\/s00120-017-0516-z","article-title":"PSMA-radioguided surgery in localised recurrent prostate cancer","volume":"56","author":"Horn","year":"2017","journal-title":"Urologe A"},{"key":"10.1016\/j.nucmedbio.2024.108938_bb0090","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1039\/C6CC09781B","article-title":"PSMA-targeted contrast agents for intraoperative imaging of prostate cancer","volume":"53","author":"Bao","year":"2017","journal-title":"Chem Commun (Camb)"},{"key":"10.1016\/j.nucmedbio.2024.108938_bb0095","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s00120-016-0275-2","article-title":"PSMA-radioguided surgery in localized recurrent prostate cancer: current and future aspects","volume":"56","author":"Rauscher","year":"2017","journal-title":"Urologie A"},{"key":"10.1016\/j.nucmedbio.2024.108938_bb0100","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1158\/1078-0432.CCR-18-0803","article-title":"Evaluation of novel prostate-specific membrane antigen-targeted near-infrared imaging agent for fluorescence-guided surgery of prostate cancer","volume":"25","author":"Kularatne","year":"2019","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.nucmedbio.2024.108938_bb0105","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1021\/bc400131a","article-title":"Development of tumor-targeted near infrared probes for fluorescence guided surgery","volume":"24","author":"Kelderhouse","year":"2013","journal-title":"Bioconjug Chem"},{"key":"10.1016\/j.nucmedbio.2024.108938_bb0110","doi-asserted-by":"crossref","first-page":"9167","DOI":"10.1002\/anie.201102872","article-title":"Sequential SPECT and optical imaging of experimental models of prostate cancer with a dual modality inhibitor of the prostate-specific membrane antigen","volume":"50","author":"Banerjee","year":"2011","journal-title":"Angew Chem Int Ed Eng"},{"key":"10.1016\/j.nucmedbio.2024.108938_bb0115","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2967\/jnumed.118.212720","article-title":"Synthesis and preclinical characterization of the PSMA-targeted hybrid tracer PSMA-I&F for nuclear and fluorescence imaging of prostate cancer","volume":"60","author":"Schottelius","year":"2019","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2024.108938_bb0120","doi-asserted-by":"crossref","first-page":"639","DOI":"10.2967\/jnumed.117.201293","article-title":"PSMA-11 derived dual-labeled PSMA-inhibitors for preoperative PET imaging and precise fluorescence-guided surgery of prostate cancer","volume":"59","author":"Baranski","year":"2018","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2024.108938_bb0125","doi-asserted-by":"crossref","first-page":"266","DOI":"10.2214\/AJR.16.16181","article-title":"Dual PET and near-infrared fluorescence imaging probes as tools for imaging in oncology","volume":"207","author":"Fei-Fei","year":"2016","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.nucmedbio.2024.108938_bb0130","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.3390\/molecules27051501","article-title":"67Cu production capabilities: a mini review","volume":"27","author":"Mou","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.nucmedbio.2024.108938_bb0135","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s11307-021-01666-1","article-title":"PET imaging of VLA-4 in a new BRAFV600E mouse model of melanoma","volume":"24","author":"Bellavia","year":"2022","journal-title":"Mol Imaging Biol"},{"key":"10.1016\/j.nucmedbio.2024.108938_bb0140","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1021\/mp5006917","article-title":"Evaluation of 68Ga-and 177Lu-DOTA-PEG4-LLP2A for VLA-4-targeted PET imaging and treatment of metastatic melanoma","volume":"12","author":"Beaino","year":"2015","journal-title":"Mol Pharm"},{"key":"10.1016\/j.nucmedbio.2024.108938_bb0145","doi-asserted-by":"crossref","first-page":"871","DOI":"10.2967\/jnumed.117.203570","article-title":"Imaging of nonprostate cancers using PSMA-targeted radiotracers: rationale, current state of the field, and a call to arms","volume":"59","author":"Salas Fragomeni","year":"2018","journal-title":"J Nucl Med"},{"key":"10.1016\/j.nucmedbio.2024.108938_bb0150","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1007\/s11307-014-0747-y","article-title":"Targeted radionuclide and fluorescence dual-modality imaging of cancer: preclinical advances and clinical translation","volume":"16","author":"L\u00fctje","year":"2014","journal-title":"Mol Imaging Biol"},{"key":"10.1016\/j.nucmedbio.2024.108938_bb0155","doi-asserted-by":"crossref","first-page":"3746","DOI":"10.1021\/acs.bioconjchem.8b00636","article-title":"Tuning pharmacokinetics to improve tumor accumulation of a prostate-specific membrane antigen-targeted phototheranostic agent","volume":"29","author":"Harmatys","year":"2018","journal-title":"Bioconjug Chem"},{"key":"10.1016\/j.nucmedbio.2024.108938_bb0160","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.7150\/thno.52166","article-title":"Photosensitizer-based multimodal PSMA-targeting ligands for intraoperative detection of prostate cancer","volume":"11","author":"Derks","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.nucmedbio.2024.108938_bb0165","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1007\/s00259-022-05685-0","article-title":"Theranostic PSMA ligands with optimized backbones for intraoperative multimodal imaging and photodynamic therapy of prostate cancer","volume":"49","author":"Derks","year":"2022","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.nucmedbio.2024.108938_bb0170","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1021\/bc990167l","article-title":"In vivo Transchelation of 64Cu from TETA-octreotide to superoxide dismutase in rat liver","volume":"11","author":"Bass","year":"2000","journal-title":"Bioconjug Chem"},{"key":"10.1016\/j.nucmedbio.2024.108938_bb0175","first-page":"6864","article-title":"Subcellular localization of radiolabeled somatostatin analogues: implications for targeted radiotherapy of cancer","volume":"63","author":"Wang","year":"2003","journal-title":"Cancer Res"}],"container-title":["Nuclear Medicine and Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805124000647?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969805124000647?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,25]],"date-time":"2024-09-25T21:05:58Z","timestamp":1727298358000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969805124000647"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":35,"alternative-id":["S0969805124000647"],"URL":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2024.108938","relation":{},"ISSN":["0969-8051"],"issn-type":[{"value":"0969-8051","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of a bimodal, matched pair theranostic agent targeting prostate-specific membrane antigen","name":"articletitle","label":"Article Title"},{"value":"Nuclear Medicine and Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nucmedbio.2024.108938","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"108938"}}